申请人:Adir Et Compagnie
公开号:US05206247A1
公开(公告)日:1993-04-27
The compounds are 8-substituted 1-oxa-2-oxo-3,8-diazaspiro [4.5]decanes useful for the treatment of dyslipidaemiae, atherosclerosis and pathologies in which membrane lipid peroxidation plays an initiating and/or aggravating role. A compound disclosed is (R,S)-8-[3(3,5-di-tert.-butyl-4-hydroxyphenylthio)-2-hydroxypropyl]-1-oxa- 2oxo-3,8-diazaspiro [4.5]decane.
这些化合物是8-取代的1-氧杂-2-酮-3,8-二氮杂螺[4.5]癸烷,可用于治疗血脂异常、动脉粥样硬化和膜脂质过氧化在疾病中起始和/或加重作用的病理生理学。其中一种化合物是(R,S)-8- [3(3,5-二叔丁基-4-羟基苯硫醚)-2-羟基丙基]-1-氧杂-2酮-3,8-二氮杂螺[4.5]癸烷。